期刊文献+

Bcl-2反义寡核苷酸对VP-16抑制人胆管癌细胞株增殖和诱导凋亡的影响 被引量:3

The effect of Bcl-2 ASODN on VP16-induced growth inhibition and apoptosis in QBC939 cells
暂未订购
导出
摘要 目的探讨bcl-2反义寡核苷酸(ASODN)对VP-16抑制人胆管癌QBC939细胞生长和诱导细胞凋亡的影响。方法合成特异性靶向Bcl-2ASODN,并将其转染QBC939细胞;四甲基噻唑蓝(MTT)试验检测Bcl-2ASODN对VP-16抑制QBC939细胞增殖的影响;流式细胞术观察Bcl-2ASODN对VP-16诱导QBC939细胞凋亡的影响。结果ASODN组细胞的存活率显著低于无义寡核苷酸(NSODN)组(P<0.05);ASODN+VP-16组细胞存活率显著低于ASODN组及VP-16组(P<0.05);ASODN组、ASODN+VP-16组和VP-16组细胞凋亡率显著高于对照组和NSODN组(P<0.05);ASODN+VP-16组细胞凋亡率显著高于ASODN组及VP-16组(P<0.05)。结论Bcl-2ASODN对VP-16抑制人胆管癌QBC939细胞生长和诱导细胞凋亡有促进作用。 Objective To investigate the effect of Bcl-2 ASODN on VP-16 induced growth inhibition and apoptosis in human bile duct carcinoma cell line QBC939. Methods Human cholangiocarcinoma cell line QBC939 was conventionally cultured. Specific target selective Bcl-2 ASODN, designed and artificially synthesized, was transfected to the cell line; MTT assay and flow cytometry (FCM) were used to study cell proliferation and apoptosis in cell line QBC939. Results MTT assay showed cell survival rate in ASODN group was significantly lower than that in NSODN group (P 〈 0.05). The survival rate in ASODN + VP-16 group was significantly lower than that in ASODN group and VP-16 group ( P 〈 0. 05 ). FCM analysis showed that apoptosis rates in ASODN group, VP-16 group and ASODN + VP-16 group were significantly higher than those in control groups ( P 〈 0. 05 ). The apoptosis rate in ASODN + VP-16 group was significantly higher than that in ASODN group and VP-16 group (P〈0.05). Conclusions Bcl-2 ASODN can enhance the effect of VP16-induced growth inhibition and apoptosis in QBC939 cell line.
出处 《中国普通外科杂志》 CAS CSCD 2007年第2期125-128,共4页 China Journal of General Surgery
基金 湖南省卫生厅科研基金资助项目(B2004-168) 湖南省科技厅科技计划项目(05SK3015)
关键词 胆管肿瘤 基因 bcl-2 寡脱氧核苷酸 反义 Bile Duct Neoplasms Gene, bcl-2 Oligodeoxynucleotides, Antisense
  • 相关文献

参考文献12

二级参考文献24

  • 1彭创,汤恢焕.Bcl-2和Bax在胆管癌中的表达及意义[J].消化外科,2004,3(6):446-448. 被引量:4
  • 2Qi Fengyang,Takeo Sakurai,Goro Yoshimura,et al.Expression of bcl-2 but not p53 correlates with in vitro resistance to a series of anticancer drugs in breast carcinoma [ J ].Breast Cancer Res Treast,2000,61 (3):211-216.
  • 3Simoes-Wast AP,Schurpt T,Hall J,et al.bcl-2 / bcl-xl bispecific antisence treatment sensitizes breast cancinoma cells to doxorubicin,paclitaxel and cyclophosphamide [ J ].Breast Cancer Res Treat,2002,76(2):157-166.
  • 4Julianne M,Patrick M,Caroline R,et al.Raf-1 and bcl-2 induce distinct and common pathways that contribute to breast cancer drug resistance [ J ].Clin Cancer Res,2003,9 (3):1 161-1 170.
  • 5Buchholz TA,Davis DW,Mcconkey DJ,et al.Chemotherapy-induced apoptosis and bcl-2 levels correlate with breast cancer response to chemotherapy [ J ].Cancer J,2003,9 ( 1 ):33-41.
  • 6Tanabe K,Kim R,Inoue H,et al.Antisense bcl-2 and HER2 oligonucletide treatment of breast cancer cells enhance their sensitivity to anticancer drugs[J].Int J Oncol,2003,22 (4):875-881.
  • 7Buchele T.Proapoptotic therapy with Oblimersen(bcl-2 antisense oligonucleotide)-review of preclinical and clinical results [ J ].Onkologic,2003,26(Suppl 7 ):60-69.
  • 8司徒镇强 吴军正.细胞培养[M].西安:世界图书版出版公司,2004.78-202.
  • 9Das PM,Singal R.DNA methylation and cancer[J].J Clin Oncol,2004,22(22):4632-4642.
  • 10Egger G,Liang G,Aparicio A,et al.Epigenetics in human disease and prospects for epigenetic therapy[J].Nature,2004,429(6990):457-463.

共引文献8

同被引文献25

  • 1何贵金,鞠光,高沁怡,许书河,高红,姜维国,蒋涛,戴显伟,马凯.犬胆管腔内放射对BCL-2基因表达的影响及其与平滑肌细胞凋亡的关系[J].中国普通外科杂志,2005,14(8):591-594. 被引量:3
  • 2高德宗,孙靖中,李永刚,邵立华,李进涛.Bcl-2和Caspase-3调控他莫昔芬诱导的ER阴性乳腺癌细胞凋亡[J].中国普通外科杂志,2005,14(9):683-686. 被引量:4
  • 3Kawin Leelawat,Surang Leelawat,Siriluck Narong,Suradej Hongeng.Roles of the MEK1/2 and AKT pathways in CXCL12/CXCR4 induced cholangiocarcinoma cell invasion[J].World Journal of Gastroenterology,2007,13(10):1561-1568. 被引量:28
  • 4Meng F, Yamagiwa Y, Ueno Y, et al. Over-expression of interleukin-6 enhances cell survival and transformed cell growth in human malignant cholangiocytes [ J ]. J Hepatol, 2006, 44(6) : 1055 -1065.
  • 5Sepulveda P, Encabo A, Carbonell U, et al. Bcl-2 expression is mainly regulated by JAK/STAT3 pathway in human CD34 + hematopoietic cells [ J ]. Cell Death and Differentiation, 2007, 14(2):378-391.
  • 6Goydos JS, Brumfield AM, Frezza E, et al. Marked elevation of serum interleukin-6 in patients with cholangiocarcinoma : validation of utility as a clinical marker [ J ]. Ann Surg, 1998, 227(2) :398 -404.
  • 7Jee SH, Shen SC, Chiu HC, et al. Over-expression of interleukin-6 in human basel cell lines increases anti-apoptotic activity and tumoergenic potency [ J]. Oncogene, 2001, 20 (2) :198 -208.
  • 8Alberti L, Thomachot MC, Bachelot T, et al. IL-6 as an intracrine growth factor for renal carcinoma cell lines [ J ]. Int J Cancer,2004 , 111 (5) :653 - 661.
  • 9Angelique Gougelet, Adeline Mansuy, Jean-Yves Blay, et al. Lymphoma and Myeloma Cell Resistance to Cytotoxic Agents and Ionizing Radiations Is Not Affected by Exposure to Anti-IL-6 Antibody [ J ]. PLoS One, 2009, 4 ( 11 ) : e8026.
  • 10Ming TL, Chiung YJ, King JC, et al. IL-6 inhibits apoptosis and retain oxidative DNA lesions in human gastric cancer AGS cells through up- greulation of anti- apoptotic gene mcl-1 [ J ] . Carcinogenesis,2001 ,22 (12) : 1947 - 1953.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部